no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|
Berger, Ashton C. |
|
|
33 |
4 |
p. 690-705.e9 |
article |
2 |
Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor
|
Huang, Jianfeng |
|
|
33 |
4 |
p. 770-784.e6 |
article |
3 |
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer
|
Wang, Ying-Nai |
|
|
33 |
4 |
p. 752-769.e8 |
article |
4 |
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|
Liu, Yang |
|
|
33 |
4 |
p. 721-735.e8 |
article |
5 |
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies
|
Yu, Xiaojie |
|
|
33 |
4 |
p. 664-675.e4 |
article |
6 |
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms
|
Kleppe, Maria |
|
|
33 |
4 |
p. 785-787 |
article |
7 |
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
|
Nakamura, Kyohei |
|
|
33 |
4 |
p. 634-648.e5 |
article |
8 |
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
|
Zappasodi, Roberta |
|
|
33 |
4 |
p. 581-598 |
article |
9 |
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
|
Arce Vargas, Frederick |
|
|
33 |
4 |
p. 649-663.e4 |
article |
10 |
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
|
Taylor, Alison M. |
|
|
33 |
4 |
p. 676-689.e3 |
article |
11 |
GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth
|
Li, Leanne |
|
|
33 |
4 |
p. 736-751.e5 |
article |
12 |
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
|
Wang, Zehua |
|
|
33 |
4 |
p. 706-720.e9 |
article |
13 |
Mechanistic Insights into Transmissible Cancers of Mammals
|
Bullman, Susan |
|
|
33 |
4 |
p. 543-544 |
article |
14 |
Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor
|
Frampton, Dan |
|
|
33 |
4 |
p. 620-633.e6 |
article |
15 |
More Rules, Still Exceptions: Understanding Immunomodulatory Antibody Activity In Vivo
|
Ipsen-Escobedo, Andrea |
|
|
33 |
4 |
p. 545-546 |
article |
16 |
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
|
Russell, Stephen J. |
|
|
33 |
4 |
p. 599-605 |
article |
17 |
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
|
Yu, Yong |
|
|
33 |
4 |
p. 785 |
article |
18 |
T Cell Dysfunction in Cancer
|
Thommen, Daniela S. |
|
|
33 |
4 |
p. 547-562 |
article |
19 |
The Immune Revolution: A Case for Priming, Not Checkpoint
|
Vonderheide, Robert H. |
|
|
33 |
4 |
p. 563-569 |
article |
20 |
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
|
Gopalakrishnan, Vancheswaran |
|
|
33 |
4 |
p. 570-580 |
article |
21 |
The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils
|
Stammnitz, Maximilian R. |
|
|
33 |
4 |
p. 607-619.e15 |
article |